IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI localized cancers: Results of the digestive non-colorectal cancer cohorts

被引：0

作者：

de la Fouchardiere, C. ^{[1
]}

Zaanan, A. ^{[2
]}

Cohen, R. ^{[3
]}

Le Sourd, S. M. ^{[4
]}

Tougeron, D. ^{[5
]}

Soularue, E. ^{[6
]}

Dubreuil, O. ^{[7
]}

Williet, N. ^{[8
]}

Samalin-Scalzi, E. ^{[9
]}

Piessen, G. ^{[10
]}

Hautefeuille, V. ^{[11
]}

Jary, M. ^{[12
]}

Ben Abdelghani, M. ^{[13
]}

Evesque, L. ^{[14
]}

Rochigneux, P. ^{[15
]}

Blanc, E. ^{[16
]}

Bibeau, F. ^{[17
]}

DeMontfort, A. ^{[18
]}

Coutzac, C. ^{[19
]}

机构：

[1] Ctr Leon Berard, Med Oncol, Lyon, France

[2] Hop Europeen Georges Pompidou, AP HP, Digest Oncol, Paris, France

[3] Hop St Antoine, Med Oncol, Paris, France

[4] Ctr Eugene Marquis, Digest Oncol, Rennes, France

[5] CHU Poitiers, Jean Bernard Hop, Gastroenterol & Digest Oncol, Poitiers, France

[6] Inst Mutualiste Montsouris, Med Oncol, Paris, France

[7] Gh Diaconesses Croix St Simon, Med Oncol, Paris, France

[8] Hop Nord St Priest Jarez, Gastroenterol & Digest Oncol, St Priest En Jarez, France

[9] ICM Inst Canc Montpellier, Med Oncol, Montpellier, France

[10] CHU Claude Huriez, Digest Surg, Lille, France

[11] CHU Amiens Picardie, Gastroenterol & Digest Oncol, Amiens, France

[12] CHU Clermont Ferrand Site Estaing, Med Oncol, Clermont Ferrand, France

[13] ICANS Inst Cancerol Strasbourg Europe, Med Oncol, Strasbourg, France

[14] Ctr Anticancer Antoine Lacassagne, GI Oncol, Nice, France

[15] IPC Inst Paoli Calmettes, Med Oncol, Marseille, France

[16] Ctr Leon Berard, Clin Res, Lyon, France

[17] CHU Besancon, Pathol, Besancon, France

[18] Ctr Leon Berard, Biostat, Lyon, France

[19] Ctr Leon Berard, Digest Oncol, Lyon, France

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.1514

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1448P

引用

页码：S899 / S900

页数：2

共 50 条

[41] STEREOTACTIC BODY RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: INTERIM RESULTS OF A PROSPECTIVE PHASE II CLINICAL TRIAL
King, Christopher R.
Brooks, James D.
Gill, Harcharan
Pawlicki, Todd
Cotrutz, Cristian
Presti, Joseph C., Jr.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1043 - 1048
[42] MR-Guided HDR Brachytherapy Boost in Localized Prostate Cancer Results of a Phase II Trial
Johnny, C.
Berlin, A.
Weersink, R. A.
Raman, S.
Glicksman, R.
Catton, C.
Rink, A.
Warde, P. R.
Lao, B.
Menard, C.
Chung, P.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E397 - E397
[43] Safety And Tolerability Of Neoadjuvant Chemoradiotherapy Combined With Pembrolizumab For Local Advanced, Resectable Esophageal Cancer: Preliminary Results Of A Prospective Phase IB Trial
Qi, W. X.
Zhao, S.
Li, H.
Chen, J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E576 - E577
[44] Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Uppaluri, Ravindra
Campbell, Katie M.
Egloff, Ann Marie
Zolkind, Paul
Skidmore, Zachary L.
Nussenbaum, Brian
Paniello, Randal C.
Rich, Jason T.
Jackson, Ryan
Pipkorn, Patrik
Michel, Loren S.
Ley, Jessica
Oppelt, Peter
Dunn, Gavin P.
Barnell, Erica K.
Spies, Nicholas C.
Lin, Tianxiang
Li, Tiantian
Mulder, David T.
Hanna, Youstina
Cirlan, Iulia
Pugh, Trevor J.
Mudianto, Tenny
Riley, Rachel
Zhou, Liye
Jo, Vickie Y.
Stachler, Matthew D.
Hanna, Glenn J.
Kass, Jason
Haddad, Robert
Schoenfeld, Jonathan D.
Gjini, Evisa
Lako, Ana
Thorstad, Wade
Gay, Hiram A.
Daly, Mackenzie
Rodig, Scott J.
Hagemann, Ian S.
Kallogjeri, Dorina
Piccirillo, Jay F.
Chernock, Rebecca D.
Griffith, Malachi
Griffith, Obi L.
Adkins, Douglas R.
CLINICAL CANCER RESEARCH, 2020, 26 (19) : 5140 - 5152
[45] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) stage IV colorectal cancer (CRC)
Andre, Thierry
Sposetti, Caterina
Gumus, Mahmut
Ahn, Joong Bae
Wyrwicz, Lucjan
Kwiatkowski, Mariusz
Kim, Jong Gwang
Yalcin, Suayib
Sendur, Mehmet A. N.
Odeleye-Ajakaye, Amos
Leconte, Pierre
Fogelman, David R.
Kim, Tae Won
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[46] Tumor microenvironment evaluation to predict pembrolizumab benefit of metastatic gastric cancer: Results from phase II clinical trial
Zeng, Dongqiang
Liao, Wangjun
Shi, Min
Zhou, Rui
Huang, Na
Yu, Yunfang
Peng, Wenying
Wu, Jiani
Ye, Zilan
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[47] A Phase II Trial of Neoadjuvant Osimertinib for Surgically Resectable EGFR-Mutant Non-Small Cell Lung Cancer: Updated Results
Blakely, C.
Urisman, A.
Kerr, D.
Wu, W.
Bacaltos, B.
Rotow, J.
Gubens, M.
Jones, K.
Bivona, T.
Joo, S.
Riess, J.
Aisner, D.
Doebele, R.
Patil, T.
Schenk, E.
Kratz, J.
Jablons, D.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1039 - S1040
[48] REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors-Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort.
Cousin, Sophie
Bellera, Carine A.
Guegan, Jean Philippe
Gomez-Roca, Carlos A.
Metges, Jean-Philippe
Adenis, Antoine
Pernot, Simon
Cantarel, Coralie
Kind, Michele
Toulmonde, Maud
Bourcier, Kevin
Soubeyran, Isabelle
Bessede, Alban
Italiano, Antoine
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[49] Phase II preoperative pembrolizumab for MSI high or MSS/PD-L1 gastric cancer followed by surgery and adjuvant therapy with pembrolizumab (NCT03257163): Results of a multicenter study
Kennedy, Timothy
Shah, Mihir Maheshkumar
Kabarriti, Rafi
Boland, Patrick M.
In, Haejin
Chen, Chunxia
Szabo, Stephen M.
Hochster, Howard S.
Moore, Dirk F.
Jabbour, Salma K.
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 441 - 441
[50] Neoadjuvant chemoradiotherapy in rectal cancer patients (pt) with oxaliplatin (Ox) and capecitabine (Cp): Results of a phase II trial
Gasent Blesa, J.
Alberola Candel, V.
Juan, O.
Provencio Pulla, M.
Giner Marco, V.
Gravalos, C.
Fernandez, I.
Llorca, C.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

← 1 2 3 4 5 →